Sildenafil Citrate Tablet, Film Coated
Product Images NDC 80425-0410

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 80425-0410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Citrate 100mg #6 (Sildenafil Citrate 100mg 80425 0410 01)

Sildenafil Citrate 100 mg film-coated tablet label showing packaging information by Advanced Rx of Tennessee, LLC, Nashville, TN. The label includes NDC codes 80425-0410-01 and 27241-0069-10, a lot number placeholder, expiration date 5/31/2026, and comparison to Viagra. It also displays storage instructions, barcode, and manufacturer Ajanta Pharma L.*

FDA Label Image

Sildenafil Citrate 100mg #12 (Sildenafil Citrate 100mg 80425 0410 02)

Sildenafil Citrate 100 mg film-coated tablet label from Advanced Rx of Tennessee, LLC. The label includes storage instructions, a comparison reference to Viagra, NDC numbers 80425-0410-02 and 27241-0069-10, lot number, expiration date 5/31/2026, and barcode. Marked Rx Only.*

FDA Label Image

Sildenafil Citrate 100mg #30 (Sildenafil Citrate 100mg 80425 0410 03)

Sildenafil Citrate 100 mg film-coated tablet label from Advanced Rx of Tennessee, LLC, Nashville, TN. Includes NDC 80425-0410, lot number placeholder, expiration date 5/31/2026, comparison to Viagra, barcode, and storage instructions to keep at 20°-25°C (68°-77°F). The label advises the drug is prescription only.*

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

A line graph comparing the mean change from baseline in sitting systolic blood pressure over 24 hours between Sildenafil 100 mg and placebo in healthy volunteers. The x-axis represents time post-dose in hours, while the y-axis shows systolic blood pressure change in mmHg. Data points for both treatment groups are plotted with distinct markers.*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' depicting changes in systolic blood pressure (mmHg) over time postdose (hours) for three groups: Doxazosin + Placebo, Doxazosin + Sildenafil 50 mg. The y-axis shows change from baseline; the x-axis shows time in hours up to 8. Curves illustrate blood pressure trends over the observed period.*

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

A line graph depicting mean standing systolic blood pressure changes from baseline over a time period of 0 to 8 hours after dosing. Two treatment groups are represented: Doxazosin with Sildenafil 100 mg and Doxazosin with Placebo, plotted as separate lines showing changes in mmHg on the vertical axis versus hours after dosing on the horizontal axis.*

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

A line graph titled 'Figure 5: Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers' showing plasma concentration (ng/ml) on the y-axis and time post dose (hours) on the x-axis. The graph plots mean plasma concentrations of sildenafil following administration of a commercial tablet, with concentrations peaking shortly after dosing and gradually declining over 24 hours.*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Bar chart showing the percentage of patients reporting improvement by treatment group. The groups are Placebo, Sildenafil Tablets 25 mg, Sildenafil Tablets 50 mg, and Sildenafil Tablets 100 mg, with increasing percentages of patients reporting improvement from left to right.*

FDA Label Image

Str (Sildenafil Structure)

Chemical structure of Sildenafil, the active ingredient in Sildenafil Citrate 100 mg tablets by Advanced Rx of Tennessee, LLC. The diagram displays the molecular arrangement including functional groups and bonds.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A line graph comparing the change in blood pressure (DBP mmHg) over time (hours) after dosing with Doxazosin plus placebo versus Doxazosin plus Sildenafil 25 mg. The graph shows two lines representing each treatment group's effect on diastolic blood pressure over a 7-hour period.*

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

A bar chart showing the percentage of patients at endpoint plotted against baseline scores from 0 to 5, with multiple grouped bars representing different categories or treatments. The y-axis represents the percentage of patients, ranging from 0 to 80%. The chart includes a legend indicating groups labeled as 0 U, 0.5 U, 1.0 U, 1.5 U, 2.0 U, and 2.5 U.*

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

Bar chart showing the percentage of patients at endpoint by baseline score, with baseline scores on the x-axis from 0 to 5 and percentage of patients on the y-axis from 0 to 80%. Multiple bars represent different groups or scores, with the highest percentages generally increasing with baseline score.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.